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ABSTRACT
Treatments of choice for cardiac implantable electronic device (CIED) infections are the removal of the entire CIED system, 
control of infection, and new device implantation. Occasionally, a complete CIED removal can not be performed for several 
reasons, such as very old age, severe comobidity, limited life expectancy, or refusal by a patient. We encountered a male pa-
tient who developed traumatic CIED infection five years after cardioverter-defibrillator implantation. An intravenous elec-
trode could not be removed by a simple transvenous extraction procedure, and he refused surgical removal of the remnant 
electrode. After control of local infection, the tips of the electrode were separated and buried between muscles, and the 
wound was closed with a local flap. CIED infection did not recur for 12 months even without relying on long-term antimi-
crobial treatment. (Korean Circ J 2011;41:46-50)
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Introduction
Once cardiovascular implantable electronic device (CIED) 
infections encroach on a pulse generator pocket, the standard 
recommended treatment is removal of all the devices includ-
ing the pulse generator and intravascular electrode(s).
1-3) If 
the electrodes are not removed, the recurrence rate of local 
or systemic infection is extraordinarily high due to remnant 
hardwares.
1)2)4-8) Although electrode removal may be easy for re-
cent CIED implantations, it may be difficult in patients whose 
electrodes have been fixed with tight fibrosis following im-
plantations performed several months or years earlier. Alth-
ough many percutaneous devices have been developed to re-
move such immobile electrodes, these procedures involve 
significant risks including cardiac tamponade, hemothorax, 
pulmonary embolism, lead migration and death, even with ex-
perienced surgeons.
4-8) When percutaneous removal of CI-
ED system is impossible, open heart surgery should be perform-
ed to remove immobile electrodes but this surgery poses con-
siderable risks. 
Occasionally, electrode removal is impossible because the 
medical condition of the patient is unsuitable for a risky oper-
ation or the procedure is refused by a patient.
9) Global expe-
rience on the management of patients with a remnant intra-
vascular electrode in CIED infection is limited. Therefore, gu-
idelines for such management have not been established yet. 
We describe a patient who refused percutaneous or surgical 
removal of an intravascular electrode and was treated effec-
tively by repositioning the electrode to a safer area between 
the pectoralis major and minor muscles without relapse into 
local or systemic infection for 12 months. This is the first re-
port of a successful repositioning of electrode procedure to 
our knowledge. 
Although this is not a standard type of management for this 
condition, it can be considered a secondary treatment in these 
cases, since it addresses the needs of patients who have re-
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Case
A 45-year-old male visited the out-patient department (OPD) 
with the primary complaint of skin erosion and pus discharge 
from a former implantable cardioverter-defibrillator (ICD) 
pocket. 
He had been engaged in Christian missionary work in No-
vosibersk, Russia for the last 15 years and had a medical his-
tory of emergency surgery at a hospital in Novosibersk in May 
1999 for primary closure of a stab injury, which penetrated 
the right ventricular free wall. He then suffered from dyspnea 
on exertion (New York Heart Association functional class 
II), palpitation and dizziness. The palpitation attacks devel-
oped and terminated suddenly, usually appearing once a 
month and lasting for a duration of 20 minutes to two hours. 
Sometimes they were relieved by deep inspiration and accom-
panied by chest discomfort, nausea and dizziness. Later on, 
palpitation attacks appeared more than once a day and loss of 
consciousness eventually developed after March 2004.
The patient visited the OPD on 15th June 2004, with a pri-
mary complaint of recurrent syncope. Two-dimensional echo-
cardiography and a treadmill test revealed no evidence of or-
ganic heart disease. Holter monitoring showed non-sustained 
but symptomatic ventricular tachycardia (VT) with dizziness 
and lightheadedness. During an electrophysiological study, 
rapid ventricular pacing could easily and reproducibly induce 
VT, which sometimes degenerated into ventricular fibrilla-
tion (VF) with a syncope and hemodynamic compromise. 
Another session of electrophysiological study was perform-
ed with continuous intravascular infusion of an anti-arrhy-
thmic agent, procainamide, without suppression of VT/VF in-
duction. A single coil ventricular electrode was inserted into 
the apex of the right ventricle through a right subclavian 
puncture. The left upper chest area could not be used because 
there were previous operative scars and fibrosis (Fig. 1). An 
ICD pulse generator was inserted subcutaneously at the 
right anterior chest without complication on 12th July 2004. 
Frequency of sustained or non-sustained VT attack decre-
ased after oral medication with amiodarone and only five VT 
attacks were recorded between 2005 and 2008. All the at-
tacks were successfully and appropriately converted to sinus 
rhythm and over the last year there were no VT/VF attacks. 
The patient experienced blunt trauma at the area of the ICD 
pocket with a broomstick in May 2009 when he slipped on 
an icy road. The ICD pocket was swollen with hematoma, and 
the ICD pulse generator began to displace downward. The 
skin over the lower lateral angle of the pulse generator was th-
inning, and the pulse generator was exposed in July 2009. Al-
though he self-sterilized the wound in Russia, pus discharge 
appeared two weeks after the erosion. He returned to Korea 
and visited the hospital. 
Fever and other signs of systemic toxicity were absent and 
the patient presented with vague symptoms such as anorex-
ia, fatigue, malaise and decreased functional capacity. A small 
cutaneous erosion with percutaneous exposure of the gener-
ator and pus discharge were evident upon inspection (Fig. 1). 
Three sets of blood culture were obtained, but he did not de-
velop any appreciable fever over 38.3°C. Empiric vancomy-
cin was initiated after the third set of blood culture. 
The generator pocket was explored on the second day of 
admission. The generator was removed, meticulous debride-
ment was performed, and cultures were obtained from the elec-
trode tips and the pocket-site tissue. Removal of the electrode 
was also tried with conventional stylets without success. The 
causative organism did not grow in all cultures and therefore, 
systemic vancomycin was continued for 14 days. The wound 
was opened and wet dressing using betadine was performed 
twice a day. The second exploration, five days after the remo-
val of the generator, revealed improved local infection and con-
sequently, little debridement was required. 
Follow-up transthoracic and transesophageal echocardiog-
raphy (TEE) showed no evidence of infective endocarditis. The 
patient refused to remove the intravascular electrode after we 
explained the risks and benefits of open heart surgery to re-
move the electrode. The third exploration of the wound was 
done 10 days after the first exploration, and the wound was 
clear enough to be closed. The tips of the electrode were care-
fully displaced apart from the infected site, repositioned be-
tween the pectoralis major and minor muscles, and the skin was 
closed using a local flap without complication (Fig. 2). He 
also refused a second ICD implantation and was recommend-
ed to take oral amiodarone for the time being. He was disch-
arged three days after wound closure, and visited the OPD 
daily for wound care. The stitches were removed 10 days after 
wound closure. First generation cephalosporin was given or-
Fig. 1. A photograph of CIED infection. The ICD pocket was displac-
ed downward and laterally, and the lower lateral edge was exposed 
by CIED erosion. The wounds at the central chest near the sternum, 
just below the left nipple, and at the left upper chest were made by 
the previous emergency operation: a primary closure of right ventri-
cular free wall due to stab injury. CIED: cardiovascular implantable 
electronic device, ICD: implantable cardioverter-defibrillator.48   Management of ICD Infection Without Electrode Removal
ally for 10 days after discharge. Regular OPD follow-up show-
ed no recurrence of infection symptoms over the next 12 
months. In addition, biomarkers, such as white blood cell 
count and differential count, erythrocyte sedimentation rate 
and C-reactive protein were normal. Palpitation or syncope did 
not develop over this period.
Discussion
Recently an American Heart Association (AHA) commit-
tee updated the guidelines on CIED infections and their man-
agement.
10) According to the guidelines, complete removal 
of all hardware, regardless of location (subcutaneous, transve-
nous or epicardial), is the recommended treatment for patients 
with established CIED infection because relapse rates of in-
fection due to retained hardware are high.
1)2)4-8) Established ma-
nagement for patients with CIED infections who are not can-
didates for device removal either by percutaneous or surgical 
methods has not been established. Often, these patients have 
a limited life expectancy or have refused device removal.
9)10) 
Fig. 2. Serial chest PA’s. A: three days after the implantation of ICD on 15th July 2004. B: established CIED infection on 2nd September 2009. 
The ICD was displaced downward and laterally, and the intracardiac electrode was tethered. C: after ICD removal on 3rd September 2009. The 
wound was exposed, and the electrode could not be removed, therefore it was exposed as well. D: the tips of the ICD side were well separated 
and buried between the pectoralis major and minor muscles, and the wound was closed using a local flap on 12th September 2009.
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Long-term antimicrobial suppressive therapy such as oral an-
tibiotics for one to two years or more may be used in selected 
patients, but little is known about relapse rates, resistant or-
ganisms, safety profiles, patient compliance and financial ex-
penses.
9) In this case, we did not try long-term antibiotic treat-
ment. Intravenous antibiotics were administered for 14 days 
while the patient was in the hospital and oral antibiotics were 
also administered for 10 more days after discharge (until the 
stitches were removed). There was no sign of recurrent infec-
tion for up to 12 months.
The length of time that antibiotics should be continued still 
needs to be resolved. According to AHA recommendations, 
blood cultures should be performed in every patient with sus-
pected CIED infection. For patients with negative cultures like 
the patient discussed in this study, 10-14 days of antibiotics 
should be sufficient. For patients with positive cultures or pri-
or antibiotic treatment, TEE is a useful test. For patients with 
negative TEE and non-S. aureus infection, 14 days of antibi-
otic treatment is sufficient. For patients with S. aureus infec-
tion, two to four weeks of antibiotic treatment are required. 
If vegetation is present in any of the cardiac valves, AHA gu-
idelines for treatment of infective endocarditis should be fol-
lowed. If complicated vegetation is found in intravascular leads, 
four to six weeks of antibiotic treatment are required. Realis-
tically, an infected generator pocket will not close in a short pe-
riod, and antibiotics should be continued until the stitches 
are removed. 
A challenging issue is whether a new CIED is mandatory 
in patients who have had all hardware removed. In this case, 
a new ICD implantation could not be performed because, 
contrary to medical advice, the patient refused the implanta-
tion. Although there were no VT/VF episodes for the past year, 
he had five episodes of symptomatic VT/VF over the previ-
ous five years, and he definitely needed a new ICD implanta-
tion. A new, transvenous device implantation should not be 
done in an ipsilateral chest with CIED infection.
10) Moreover, 
this patient had a remnant intravascular electrode through 
the right subclavian vein and an ipsilateral transvenous pro-
cedure might spread local infection directly into the blood 
stream. He also had previous emergency open-heart surgery 
scars on the anterior mid-chest, left lower chest, and at the left 
upper chest area where a new ICD should be placed (Fig. 1). 
The only option for a new ICD in this patient was epicardial 
ICD with general anesthesia and open chest surgery. There-
fore, he decided not to have a new ICD and to take long-term 
oral amiodarone. But in most patients with CIED infection, 
each patient should be re-evaluated to determine whether a 
new CIED is necessary. One third to one half of patients in 
some study will not require a new CIED placement.
2) 
Another challenging issue is at what time a new CIED sh-
ould be implanted in patients with CIED infection. The op-
timal timing of device replacement is unknown. If the infec-
tion is confined to the pocket, replacement after 72 hours of 
negative blood culture is generally accepted. However, if there 
is valve vegetation, implantation of a new CIED should be 
delayed 14 days from the first negative blood culture.
2)5)11) 
CIED infection is associated with substantial morbidity 
and mortality. Higher mortality is reported in patients with 
confirmed endocarditis and in those treated without device re-
moval.
11-15) All-cause mortality at six months with CIED infec-
tion was shown to be 18%, and variables associated with in-
creased risk were systemic embolization, moderate to severe 
tricuspid regurgitation, abnormal right ventricular function 
and abnormal renal function.
16) 
Prevention of CIED infection is vital. Parenteral antibiotic 
prophylaxis, antiseptic preparation of the surgical site, a steri-
le technique, prevention of hematoma through meticulous 
bleeding control, irrigation with antimicrobial-containing so-
lution for pocket cleansing, use of monofilament suture in 
the subcutaneous layer, pressure dressing for 12 to 24 hours 
after skin closure, and early follow-up after discharge all re-
duced CIED infection.
10)17)18) Also, special attention should 
be paid to patients at greater risk of CIED infection. These risk 
factors include 1) renal dysfunction, 2) immunosuppression 
(corticosteroid use), 3) oral anticoagulation, 4) coexisting ill-
ness, 5) periprocedural factors (failure to administrate prophy-
lactic antibiotic), 6) device revision-replacement, 7) operator 
experience, 8) the amount of indwelling hardware, and 9) the 
microbiology of the infectious organism.
13)18-25) 
Limited data on CIED infections are available in Korea. 
Choi et al.
26) reported a long-term follow-up of 440 patients 
with permanent pacemaker implantation and only six CIED 
infections were reported. All the infections developed shortly 
after the implantation, and there were no difficulties in remo-
ving the entire CIED system. After the first ICD implantation 
in Korea, there was only one available ICD follow-up report 
on 28 patients, and the ICD infection did not appear.
27)28) In 
Korea, CIED infection may increase because CIED implan-
tation, revision/replacement, and implantation in patients with 
medical illness are increasing. Morbidity, mortality and cost 
are substantial in the treatment of CIED infection and the pre-
vention of infection is of primary importance in CIED impl-
antation.
Although the clinical course and pathophysiology of late-
onset (six months after CIED implantation) CIED infections 
are not known, all devices should be removed in patients with 
established CIED. There were no signs of infection for 12 
months in this patient. However, a chance of infection recur-
rence remains if the pathogen is dormant. Therefore, the tr-
eatment shown in this case should not be generalized and 
only considered as an auxiliary method in exceptional condi-
tions such as very old age, severe co-morbidity, limited life 
expectancy, or refusal by a patient. 50   Management of ICD Infection Without Electrode Removal
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